Connors JM - Search Results

1

Antifibrinolytic Agents for Hemoptysis Management in Adults With Cystic Fibrosis.

Al-Samkari H, Shin K, Cardoni L, Pighetti EH, Rits S, McMahon L, Perkins R, Uluer A, Connors JM. Al-Samkari H, et al. Among authors: connors jm. Chest. 2019 Jun;155(6):1226-1233. doi: 10.1016/j.chest.2019.02.010. Epub 2019 Feb 18. Chest. 2019. PMID: 30790551

2

Aminocaproic acid for the management of bleeding in patients on extracorporeal membrane oxygenation: Four adult case reports and a review of the literature.

Buckley LF, Reardon DP, Camp PC, Weinhouse GL, Silver DA, Couper GS, Connors JM. Buckley LF, et al. Among authors: connors jm. Heart Lung. 2016 May-Jun;45(3):232-6. doi: 10.1016/j.hrtlng.2016.01.011. Epub 2016 Feb 20. Heart Lung. 2016. PMID: 26907195 Review.

3

Anticoagulation and Enzalutamide: Caution Over Convenience.

Al-Samkari H, Connors JM. Al-Samkari H, et al. Among authors: connors jm. J Oncol Pract. 2017 Nov;13(11):728-729. doi: 10.1200/JOP.2017.027664. J Oncol Pract. 2017. PMID: 29125926 No abstract available.

4

Ofatumumab for acute treatment and prophylaxis of a patient with multiple relapses of acquired thrombotic thrombocytopenic purpura.

Al-Samkari H, Grace RF, Connors JM. Al-Samkari H, et al. Among authors: connors jm. J Thromb Thrombolysis. 2018 Jul;46(1):81-83. doi: 10.1007/s11239-018-1647-9. J Thromb Thrombolysis. 2018. PMID: 29564686

5

Dual anticoagulation with fondaparinux and dabigatran for treatment of cancer-associated hypercoagulability.

Al-Samkari H, Connors JM. Al-Samkari H, et al. Among authors: connors jm. Am J Hematol. 2018 Jun;93(6):E156-E158. doi: 10.1002/ajh.25101. Epub 2018 Apr 18. Am J Hematol. 2018. PMID: 29603336 Free article. No abstract available.

6

The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis.

Al-Samkari H, Connors JM. Al-Samkari H, et al. Among authors: connors jm. Cancers (Basel). 2018 Aug 15;10(8):271. doi: 10.3390/cancers10080271. Cancers (Basel). 2018. PMID: 30111746 Free PMC article. Review.

7

Thrombophilia evaluation in pulmonary embolism.

Stern RM, Al-Samkari H, Connors JM. Stern RM, et al. Among authors: connors jm. Curr Opin Cardiol. 2019 Nov;34(6):603-609. doi: 10.1097/HCO.0000000000000668. Curr Opin Cardiol. 2019. PMID: 31389825 Review.

8

Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients.

Song AB, Rosovsky RP, Connors JM, Al-Samkari H. Song AB, et al. Among authors: connors jm. Vasc Health Risk Manag. 2019 Jun 21;15:175-186. doi: 10.2147/VHRM.S132556. eCollection 2019. Vasc Health Risk Manag. 2019. PMID: 31417269 Free PMC article. Review.

9

Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.

Al-Samkari H, Connors JM. Al-Samkari H, et al. Among authors: connors jm. Blood Adv. 2019 Nov 26;3(22):3770-3779. doi: 10.1182/bloodadvances.2019000369. Blood Adv. 2019. PMID: 31770442 Free PMC article. Review.

10

Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.

Al-Samkari H, Connors JM. Al-Samkari H, et al. Among authors: connors jm. Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):71-79. doi: 10.1182/hematology.2019000369. Hematology Am Soc Hematol Educ Program. 2019. PMID: 31808892 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

762 results

Search Page

Filters